How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Anticoagulated Blood Collection Tube Market
- By Tube Type: Vacuum Blood Collection Tubes, Non-Vacuum Blood Collection Tubes, Capillary Blood Collection Tubes
- By Anticoagulant Type: EDTA (Ethylenediaminetetraacetic Acid) Tubes, Sodium Citrate Tubes, Heparin Tubes, Oxalate Tubes, Fluoride Tubes
- By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Research Institutes, Clinics
- By Application: Hematology Testing, Coagulation Testing, Biochemistry Testing, Blood Gas Analysis, Molecular Diagnostics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Vacuum Blood Collection Tubes leads By Tube Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 270 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.167 →
- 11 Company Profiles 12 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the Anticoagulated Blood Collection Tube Market report
A complete, evidence-based study - 11 chapters and 113 sections covering market size, segmentation across 4 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Tube Type 3
Anticoagulant Type 5
End User 5
Application 5
Companies profiled
Becton
Dickinson and Company (BD)
Greiner Bio-One International GmbH
Terumo Corporation
Sartorius AG
Sarstedt AG & Co.
Nipro Corporation
Kangjian Medical Apparatus Co. Ltd.
Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Shandong Weigao Group Medical Polymer Company Limited
Hengshui Jinjian Medical Instrument Co. Ltd.
Ningbo David Medical Device Co. Ltd.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Sarstedt AG & Co.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Kangjian Medical Apparatus Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shandong Weigao Group Medical Polymer Company Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Hengshui Jinjian Medical Instrument Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Ningbo David Medical Device Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,657M by 2033 · 6.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Vacuum Blood Collection Tubes71.2
- Non-Vacuum Blood Collection Tubes14.4
- Capillary Blood Collection Tubes14.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,319M → $2,088M · 5.9%
Europe$919.5M → $1,524M · 6.5%
Asia Pacific$839.5M → $1,295M · 5.6%
Latin America$519.7M → $826.6M · 6.0%
Middle East and Africa$399.8M → $644.2M · 6.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.532026
6.542027
6.562028
6.562029
6.592030
6.602031
6.612032
6.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton14.3
- Dickinson and Company (BD)20.2
- Greiner Bio-One International GmbH11.0
- Terumo Corporation8.1
- Sartorius AG11.4
- Sarstedt AG & Co.7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Tube Type23.8%
Anticoagulant Type28.4%
End User21.2%
Application26.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.7
- Europe23.9
- Asia Pacific20.3
- Latin America13.0
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton | 81 | 97 | 84 | 89 | 88 | 75 | 86 |
| Dickinson and Company (BD) | 91 | 82 | 75 | 70 | 73 | 85 | 79 |
| Greiner Bio-One International GmbH | 73 | 88 | 78 | 68 | 75 | 70 | 75 |
| Terumo Corporation | 73 | 82 | 61 | 77 | 67 | 71 | 72 |
| Sartorius AG | 72 | 58 | 75 | 64 | 74 | 55 | 66 |
| Sarstedt AG & Co. | 50 | 66 | 67 | 68 | 54 | 70 | 63 |
| Nipro Corporation | 55 | 46 | 43 | 47 | 61 | 59 | 52 |
| Kangjian Medical Apparatus Co. Ltd. | 47 | 36 | 55 | 50 | 57 | 39 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton
- Dickinson and Company (BD)
- Greiner Bio-One International GmbH
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Dickinson and Company (BD) | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Greiner Bio-One International GmbH | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Terumo Corporation | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Sartorius AG | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Sarstedt AG & Co. | − | ◐ | ◐ | ✓ | ◐ | ✓ |
| Nipro Corporation | ◐ | − | ◐ | − | − | − |
| Kangjian Medical Apparatus Co. Ltd. | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton86
2Dickinson and Company (BD)79
3Greiner Bio-One International GmbH75
4Terumo Corporation72
5Sartorius AG66
6Sarstedt AG & Co.63
7Nipro Corporation52
8Kangjian Medical Apparatus Co. Ltd.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BectonDickinson and Company (BD)
Challenger2
Strong scale, closing on the leaders.
Greiner Bio-One International GmbHTerumo Corporation
Contender2
Focused players with pockets of strength.
Sartorius AGSarstedt AG & Co.
Niche2
Specialists in a single segment or region.
Nipro CorporationKangjian Medical Apparatus Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Tube Type in North America, then scale across Anticoagulated Blood Collection Tube Market — a $653M beachhead inside a $11.3B market.
Beachhead (SOM)$653Mobtainable near-term
Serviceable (SAM)$4.20Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Vacuum Blood Collection Tubes
Best fit — highest urgency & budget in Tube Type.
Economic buyer78 fit
Non-Vacuum Blood Collection Tubes
Strong fit — clear ROI and a fast path to value.
End user67 fit
Capillary Blood Collection Tubes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Tube Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Anticoagulant Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Tube Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Anticoagulated Blood Collection Tube Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation13%
Closed-won6%
$11.0KCAC
$62KLTV
5.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Anticoagulated Blood Collection Tube Market is a resilient opportunity — $7.56B by 2033, compounding at 3.9%.
TAM · 2025$5.59Btoday
TAM · 2033$7.56Bforecast
CAGR3.9%2027–2033
Cumulative$58.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.56BTotal addressable market
SAM$2.74BServiceable available market
SOM$597MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.9% CAGR
Demand compounds through 2033, outpacing GDP across Tube Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Tube Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.56BLarge & growingTAM by 2033 at 3.9% CAGR
$2.74BServiceable nowreachable with today’s model
$597MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.90BBear2.5% CAGR
$7.56BBase3.9% CAGR
$9.68BBull5.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Anticoagulant Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Anticoagulated Blood Collection Tube Market — a $6.48B market by 2033. Plan: grow share from 11.2% to 17.3%.
Market size · 2033$6.48Btotal addressable
Market CAGR3.3%2027–2033
Target share17.3%from 11.2% today
Revenue ambition$1.12Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.2% | 17.3% | Ahead |
| Revenue | $660M | $1.12B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 34.0% | 41.5% | On track |
| Customer retention | 86.8% | 93.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Tube Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Anticoagulant Type capability
A defensible second engine — invest in Anticoagulant Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Tube Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Anticoagulant Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $162M capacity & capability investment
- Greenlight bolt-on M&A in Anticoagulant Type
- Authorise North America expansion plan
- Fund R&D program for Tube Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Anticoagulated Blood Collection Tube Market conversation — a $671M market you can size, segment and defend in minutes.
Market size · 2033$671Mtotal opportunity
Growth3.6%CAGR to 2033
Addressable buyers1,090+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Tube Type
Goal Grow share in Tube Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 2 mopayback period
$69K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
BectonDickinson and Company (BD)Greiner Bio-One International GmbHTerumo CorporationSartorius AGSarstedt AG & Co.Nipro CorporationKangjian Medical Apparatus Co. Ltd.+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Anticoagulated Blood Collection Tube Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Anticoagulated Blood Collection Tube Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Anticoagulation Agents Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportAnti-Collapse Mesh Safety System Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportAnti-Collision Clothing for Elderly Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportAnticollision Indicator Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportAnticonvulsant Pain Drug Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportAnticonvulsants Drugs Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportAnti-corrosion Coatings for Steel Structure Market
Market size, share, segmentation and regional forecast.
$652M market · 2025 base year
View reportAnticorrosion Cut-Off Valve Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportAnti-corrosion Fume Hood Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportAnti-Corrosion Lining Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportAnti-Corrosion Materials for Wind Turbine Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportAnti-corrosion Paints and Coatings Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.